Safety and Tolerability of Physcion in Healthy Volunteers in a Phase I Dose Escalating Clinical Pharmacology Study

被引：0
|
作者：
Tzeng, Tsang-Bin
Chang, Wei-Kuo
Huang, Tien-Yu
Wu, Pei-Tzu
Huang, Wen-Chuan
Lee, Catherine
Wu, Hsing-Hua
Lai, Henry
Chang, Yi-Wei
Lee, Ming-Chung
Kung, Li-Pin
Friedman, Hylar
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S572 / S572
页数：1
相关论文
共 50 条
  • [21] Safety evaluation of BacoMind™ in healthy volunteers:: A phase I study
    Pravina, K.
    Ravindra, K. R.
    Goudar, K. S.
    Vinod, D. R.
    Joshua, A. J.
    Wasim, P.
    Venkateshwarlu, K.
    Saxena, V. S.
    Amit, A.
    PHYTOMEDICINE, 2007, 14 (05) : 301 - 308
  • [22] Phase I study assessing the safety, tolerability, and pharmacokinetics of avibactam and ceftazidime-avibactam in healthy Japanese volunteers
    Tominaga, Nobumitsu
    Edeki, Timi
    Li, James
    Learoyd, Maria
    Bouw, M. Rene
    Das, Shampa
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2015, 21 (08) : 551 - 558
  • [23] Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers
    Al-Karagholi, Mohammad Al-Mandi
    Hansen, Jakob Moller
    Abou-Kassem, Dalia
    Hansted, Anna Koldbro
    Ubhayasekera, Kumari
    Bergquist, Jonas
    Vecsei, Laszlo
    Jansen-Olesen, Inger
    Ashina, Messoud
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (02):
  • [24] A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers
    Susanne Johansson
    David P. Rosenbaum
    Mikael Knutsson
    Maria Leonsson-Zachrisson
    Clinical and Experimental Nephrology, 2017, 21 : 407 - 416
  • [25] A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers
    Johansson, Susanne
    Rosenbaum, David P.
    Knutsson, Mikael
    Leonsson-Zachrisson, Maria
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (03) : 407 - 416
  • [26] Phase I, Single-Dose Study to Assess the Pharmacokinetics and Safety of Suramin in Healthy Chinese Volunteers
    Wu, Guolan
    Zhou, Huili
    Lv, Duo
    Zheng, Ruling
    Wu, Lihua
    Yu, Songxia
    Kai, Jiejing
    Xu, Nana
    Gu, Lie
    Hong, Nanfang
    Shentu, Jianzhong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 2051 - 2061
  • [27] Clinical tolerability and pharmacokinetics of Erigerontis hydroxybenzene injection: Results of a randomized phase I study in healthy Chinese volunteers
    Ju, Wen-Zheng
    Zhao, Yang
    Liu, Fang
    Wu, Ting
    Zhang, Jun
    Liu, Shi-Jia
    Zhou, Ling
    Dai, Guo-Liang
    Xiong, Ning-Ning
    Fang, Zhu-Yuan
    PHYTOMEDICINE, 2015, 22 (02) : 319 - 325
  • [28] DOSE-FINDING AND TOLERABILITY STUDY OF MEDETOMIDINE IN 4 HEALTHY-VOLUNTEERS - AN OPEN PHASE-I INVESTIGATION
    SCHEININ, M
    KALLIO, A
    KOULU, M
    ARSTILA, M
    VIIKARI, J
    SCHEININ, H
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1987, 41 (05): : 637 - 646
  • [29] Safety and tolerability of subcutaneous PTHrP(1–36) in healthy human volunteers: a dose escalation study
    Mara J. Horwitz
    Mary Beth Tedesco
    Susan M. Sereika
    Adolfo Garcia-Ocaña
    Alessandro Bisello
    Bruce W. Hollis
    Caren Gundberg
    Andrew F. Stewart
    Osteoporosis International, 2006, 17 : 225 - 230
  • [30] Safety, tolerability, and pharmacokinetics of amuvatinib from three phase 1 clinical studies in healthy volunteers
    Choy, Gavin
    Joshi-Hangal, Rajashree
    Oganesian, Aram
    Fine, Gil
    Rasmussen, Scott
    Collier, Joanne
    Kissling, James
    Sahai, Amarpal
    Azab, Mohammad
    Redkar, Sanjeev
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (01) : 183 - 190
12345